Blog

Increased Market Demand for Ulthera’s Ultrasound Platform Technology Fuels …

Posted by:


MESA, AZ, Jul 25, 2012 (MARKETWIRE via COMTEX) —
Ulthera, Inc. — a global, growth-stage medical device company
pioneering aesthetic and medical applications using its therapeutic
ultrasound platform technology — today announced that more than
1,000 Ulthera Systems have been sold globally while treatments
performed using the System have surpassed 100,000.

In the first half of 2012, expansion into Latin America as well as
further penetration of markets in Europe, Asia and North America
continued to accelerate quarterly sales growth. According to Matthew
Likens, president and CEO of Ulthera, “There has been a significant
increase in the number of Ultherapy procedures performed this year,
making it apparent that the word is out; both physicians and
consumers have discovered that Ultherapy is the most consistently
efficacious non-surgical procedure to lift and tighten skin.”

Likens added, “Our goal as an organization is to reward those
customers who have invested in our technology by bringing them more
value during each year of ownership. This value will be realized
through expanded clinical indications, elevated marketing programs,
and ongoing product enhancements.”

The Ulthera System is the first and only energy-based device to
receive FDA clearance for a non-invasive aesthetic lift indication,
and its signature procedure, Ultherapy, is a non-invasive treatment
of the face to achieve a brow lift. The Ulthera System — which
combines time-honored ultrasound imaging with focused ultrasound
therapy — has been available internationally since 2008 and in the
US since September 2009.

About Ulthera
Ulthera(R), Inc. is a global, growth-stage medical
device company pioneering aesthetic and medical applications using
its therapeutic ultrasound platform technology. The Ulthera(R) System
is the first and only energy-based device to receive FDA clearance
for a non-invasive aesthetic lift indication. The first application
for Ultherapy(R) — the procedure enabled by the System — is a
non-invasive treatment of the face to achieve a brow lift. Founded in
2004 and based in Mesa, Ariz., Ulthera is a privately held company
backed by top tier venture capital firms, New Enterprise Associates
and Apposite Capital. For more information, visit
www.ulthera.com .



        
        Media Contact:
        Lindsey Karberg
        Ulthera, Inc.
        480.336.1744
        Email Contact
        
        
        


SOURCE: Ulthera



 
http://www2.marketwire.com/mw/emailprcntct?id=F8E7290A82628DDF            


Copyright 2012 Marketwire, Inc., All rights reserved.

0


About the Author:

Paul Khunkhun, serving Southern California since 1998. Paul is the owner of MDIS. He is a Board Certified Ultrasound Sonographer with RDCS and RVT credentialing. He is also pending ICAEL accreditation.

Add a Comment